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The dynamic evaluation of Parkinson’s disease (PD)-related episodic gait disturbances in routine is
challenging. Therefore, the aim of our study was to assess the reliability/validity of the Dynamic Par-
kinson Gait Scale (DYPAGS) composed of eight relevant items for the objective quantiﬁcation of PD gait
features: walking forwards/backwards/with dual-task, turning to both sides, imaginary obstacle avoid-
ance with both legs and passing through narrow spaces. The scale was validated on thirty-ﬁve patients
with mild to severe parkinsonism in their habitual “on-state”. A shorter 6 item-version was designed on
the basis of a principal component analysis. No signiﬁcant ﬂoor/ceiling effect was detected. The internal
consistency was excellent. The levels of interrater agreement, precision and minimal detectable change
were adequate. The criterion-related validity was demonstrated by strong correlations with the DYPAGS
scores and those at the gait subscales of the Tinetti Mobility Test and MDS-UPDRS. The construct validity
was assessed by moderate-strong correlations with the Freezing of Gait Questionnaire, mobility index of
the PD Questionnaire (PDQ-39), disease duration and levodopa equivalent daily doses. Statistical anal-
yses using the coefﬁcient of determination showed that both DYPGAS versions were superior to the other
instruments to identify patients with gait disturbances with poorer response to dopaminergic treatment.
Full and short DYPAGS are reliable instruments for the quantiﬁcation of “on” PD-related episodic gait
disturbances. The full version is sensitive to detect subtle disturbances in mild parkinsonism. The shorter
one is easily administered and reliably quantiﬁes gait disturbances in moderate to severe parkinsonism.
We recommend their use for research and clinical practice.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Episodic gait disturbances are highly disabling in Parkinson’s
disease (PD). They encompass a wide continuous spectrum of
manifestations ranging from subtle hesitation to minutes of gait
akinesia [1]. They preferentially occur during certain phases of gait
which are ignition, making a turn or approaching the target, and in
situations that differ from the “baseline gait” such as passing
through narrow passages, walking while performing a dual-task
[1e3], and walking backwards [4]. Quantifying these disturbances
is of importance as the therapeutic approach may depend on their
severity. Habitual PD-related gait disturbances may be assessed
using non-dynamic instruments such as the Freezing of Gait
Questionnaire (FOG-Q) [2]. Additionally to the clinician’s judgment
which remains the gold standard, several instruments may beesearch Center (B30), 8 Allée
émers).
All rights reserved.
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These instruments have however major limitations: they lack
sensitivity, they categorize patients as with/without severe gait
disturbances (i.e., gait freezing) which should be considered as
a continuum with numerous intermediate stages [1], they do not
reﬂect habitual gait, or their performances are altered by fatigue
rather than speciﬁc PD-related gait disturbances.
Here, we assess the reliability and validity of the full and short
versions of the Dynamic Parkinson Gait Scale (DYPAGS) aiming at




Thirty-two patients diagnosedwith PD [12] and threewith probable “Parkinson-
plus syndromes” were recruited in their “habitual on-state” (Table 1). Written
consents for this research protocol approved by the local Ethic Committee were
obtained from all patients.
Habitual gait disturbances were evaluated using the FOG-Q and the mobility
index of the PD Questionnaire (PDQ-39gait) [13]. Motor scores at the Movementtion of the Dynamic Parkinson Gait Scale (DYPAGS), Parkinsonism and
Table 1
Demographic and clinical patients’ data and their relationship with the full and short versions of the Dynamic Parkinson Gait Scale (DYPAGS).




Age (years) 66.2  8.9 66 0.10 (P ¼ 0.551) 0.16 (P ¼ 0.362)
Gender (male %) 74.3  44.3 100 0.13 (P ¼ 0.469) 0.08 (P ¼ 0.629)
Disease duration (years) 8.1  4.7 8 0.44 (P ¼ 0.011)* 0.45 (P ¼ 0.011)
Levodopa equivalent daily
doses (mg)
824  413 812 0.48 (P ¼ 0.004)** 0.40 (P ¼ 0.019)*
FOG-Q 9.8  6.1 8 0.74 (P < 0.001)** 0.74 (P < 0.001)**
PDQ-39mobility 35.3  23.7 35 0.58 (P < 0.001)** 0.56 (P < 0.001)**
MDS-UPDRSgait 2.1  2 1 0.81 (P < 0.001)** 0.82 (P < 0.001)**
TMTgait score 8.8  3.2 10 0.71 (P < 0.001)** 0.73 (P < 0.001)**
DYPAGS 13.3  8.7 11 n/a 0.99 (P < 0.001)**
Short DYPAGS 9.3  6.6 8 0.99 (P < 0.001)** n/a
SD ¼ standard deviation. rs ¼ Spearman rank correlation coefﬁcient. FOG-Q ¼ Freezing of Gait Questionnaire. PDQ-39mobility ¼ mobility index of the Parkinson’s disease
Questionnaire (PDQ-39). MDS-UPDRSgait ¼ summed scores of items 3.10 (gait) and 3.11 (gait freezing) of the Movement Disorders Society sponsored review of the Uniﬁed
Parkinson’s Disease Rating Scale. TMTgait ¼ gait subscale of the Tinetti Mobility Test. DYPAGS ¼ 8 item-Dynamic Parkinson Gait Scale. short DYPAGS ¼ 6 item-DYPAGS.
n/a ¼ not applicable.
* ¼ signiﬁcant without Bonferroni correction. ** ¼ signiﬁcant after Bonferroni correction.
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(MDS-UPDRS) [14], and scores at the gait subscale of the Tinetti Mobility Test
(TMTgait) [8] were obtained prior to the administration of the DYPAGS.2.2. Construction of the DYPAGS
We made a review of articles that mentioned dynamic instruments used to
assess gait disturbances in parkinsonism. These were the items 3.10 (gait) and 3.11
(gait freezing) of the MDS-UPDRS [14], TMTgait [8], 6 min-walking distance [6], 10 m-
walk test [9], StandeWalkeSit test [5], Timed up and Go test [7,10], Dynamic Gait
Index [7] and FOG-score [11]. All items of these instruments were analyzed in order
to select those felt the most relevant to elicit PD-related gait disturbances and to
reﬂect the spectrum of gait in the patients’ habitual environment.
Eight dynamic items were adapted from these instruments: walking 7 m
forwards, walking 3 m backwards, turning 360 on the same place to the right/left,
stepping over an imaginary obstacle with the right/left leg, passing through a 50 cm-
space made between two chairs, and walking while performing a cognitive dual-
task that consisted in quoting animal names (see Appendix).
To design the scoring algorithm, we selected PD-related gait features that
could be visually unmasked: start/destination/turning hesitation, step count,
increased double-support time, foot clearance, fall/near fall, motor block (deﬁned
as the foot stuck onto the ground with or without trembling in place during >1 s),
and accelerated short shufﬂing steps [1,3]. Each item obeyed a 6 point-ordinal
scoring system (range: 0e5). A high score (maximum possible total score: 40)
reﬂected severe PD-related gait disturbances. The scoring system followed
a stepwise judgment. In all items, the inability to move the leading foot (complete
akinesia) and/or fall was considered as item maximum possible score. In items
whose achievement required a predeﬁned distance (walking forwards with/
without dual-task and walking backwards) or revolution (turning to the right/left),
the inability to perform the task in its integrality and/or near fall was scored 4. In
achieved items involving straight locomotion (walking forwards with/without
dual-task and walking backwards), narrowing the range of scores from 3 to 0, score
was assessed on the basis of our intuitive appreciation of PD-related gait distur-
bances according to the following paradigm: motor block/accelerated short
steps > hesitation/impaired feet clearance > slow gait/increased double-support/
subtle hesitation> normal gait. In the case of walking with dual-task, the quality of
the cognitive task was veriﬁed by counting the number of correct quotations. InTable 2
Comparison of the paired turning and imaginary obstacle avoidance items in function o
Turning
Less affected side Mo
Mean  SD 1.71  1.29 2.1
Median 1 2
Correlation with FOG-Q (R2) 0.52 0.5
Correlation with MDS-UPDRSgait (R2) 0.63 0.5
SD ¼ standard deviation. FOG-Q ¼ Freezing of Gait Questionnaire. MDS-UPDRSgait ¼ sum
Society sponsored review of the Uniﬁed Parkinson’s Disease Rating Scale. R2 ¼ coefﬁcient
to the more affected side were higher than those related to the less affected side (P <
affected compared with the less affected leg (P ¼ 0.006).
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imaginary obstacle avoidance, the score was an inverse function of the step width
relatively to the patient’s height. Finally, when patients could pass through tight
quarters, their scores were related to hesitation and/or motor block/accelerated
short steps between the chairs.
2.3. DYPAGS administration
The patients were asked to perform all the tasks ﬂuently as soon as they heard
the start-signal. During the cognitive dual-task, they were asked to quote as many
animal names as possible. They were asked to perform turning with minimal
number of steps. During the imaginary obstacle avoidance, they were requested to
make the widest step (assessed online with a tape-measure) as possible.
The DYPAGS administration was video-taped and the visual analysis of all the
data, exception to the “imaginary obstacle avoidance” items, was performed ofﬂine
using a media player equipped with a timer allowing the assessment of <1 s versus
>1 s hesitations. Items were scored by four neurologists blinded towards the others
using the proposed algorithm (see Appendix).
2.4. Statistical analyses
The scores measured by rater 1 were used to perform statistics against clinical
data, principal component analysis and to verify the ﬂoor and ceiling effects, internal
consistency and standard error of measurement. The paired “turning” and “imagi-
nary obstacle avoidance” scores were corrected in function of the more affected side
instead of right/left laterality.
Data analyses were conducted using the R Project for Statistical Computing
version 2.13.1 (http://www.r-project.org).
2.4.1. Scale construction
A correlation matrix expressing the relationships among all the items scored in
the ﬁfty-ﬁve subjects was computed in order to verify item redundancy. Two items
were considered as potentially redundant if their Spearman correlation coefﬁcient
exceeded 0.80. As the paired “turning” and “imaginary obstacle avoidance” items
met this criterion (see results), only one of each condition was selected on the basis
of its capacity to predict habitual PD-related gait disturbances. This was assessed
using the coefﬁcient of determination R2 between the item score and scores atf the disease laterality.
Imaginary obstacle avoidance
re affected side Less affected side More affected side




med scores of items 3.10 (gait) and 3.11 (gait freezing) of the Movement Disorders
of determination. PairedWilcoxon rank tests showed that the turning scores related
0.001), so were the imaginary obstacle avoidance scores performed with the more
tion of the Dynamic Parkinson Gait Scale (DYPAGS), Parkinsonism and
J. Crémers et al. / Parkinsonism and Related Disorders xxx (2012) 1e6 3instruments exploring gait in PD (Table 2). A 6 item-scale (the short DYPAGS, worst
total possible score: 30) was subsequently adapted from the DYPAGS (see Appendix).
The ranges of scores of both scales were compared. A principal component analysis
with varimax orthogonal rotation was conducted on the short DYPAGS.
Communalities > 0.38 in absolute value were considered as items loading on the
ﬁrst principal component [15].
2.4.2. Floor and ceiling effects
We veriﬁed ﬂoor and ceiling effects by calculating the percentage of patients
with very low or high scores which were liberally deﬁned on the basis of the ranges
of scores (Fig. 1A). Floor or ceiling effects were considered to be present if 15% of
patients achieved the very low or high scores [16].
2.4.3. Reliability of the scales
The internal consistency, interrater agreement and standard error of measure-
ment of the full and short DYPAGS were used to determine their reliability.
The internal consistency was assessed with aCronbach whose values 0.90 were
considered as excellent [17]. It was moreover veriﬁed by correlations of each item
scores versus DYPAGS scores without inclusion of the analyzed item using Spearman
correlation testing whose acceptable level was set at rs ¼ 0.70.
The interrater reliability was assessed without the two “imaginary obstacle
avoidance” items because of the impossibility to objectively measure the step width
on video recordings.
The interrater reliability was determined using non-parametric statistical
measures of agreement among 3 raters for ordinal data: the Krippendorff’s coef-
ﬁcient (aKrippendorff) [18] and Kendall’s concordance coefﬁcient (WKendall) [19].
Additionally, the interrater reliability was determined by intraclass correlation
coefﬁcients (ICC) derived using a one-way random effects analysis of variancemodel
[20]. The acceptable level of aKrippendorff was set at 0.67 [18]. Values of WKendall and
ICC 0.75 were interpreted as acceptable agreement [20].
The precision of both full and short DYPAGS was evaluated using the standard
error of measurement (SEM) deﬁned as follows: SEM ¼ SD  O(1  ICC) [20] where
SD is the standard deviation of the scales.
Scales minimal detectable changes were 1.96  O2  SEM, according to the
simpliﬁed formula [20] and were expressed in percentage of the scales maximum
possible score. A value <30% was considered acceptable [7].
2.4.4. Validity of the scales
All aspects of the validity of the full and short DYPAGS were determined using
Spearman correlation coefﬁcient. The magnitude of correlation was classiﬁed as
follows: 0.3e0.49, moderate; 50, strong [22]. Because of multiple correlations (i.e.,
6), the signiﬁcant level was set at a lower threshold (P  0.008) using Bonferroni
correction.Fig. 1. A. Ranges of scores of the full and short versions of the Dynamic Parkinson Gait
considered as very low and very high, respectively. B. Principal component analysis conduc
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short DYPAGS scores and those at other gait instruments: the TMTgait which has
previously been used to detect PD-like gait manifestations in older adults [21] and
has shown reliability in assessing themobility status of PD patients [8], and summed
scores at items 3.10 (gait) and 3.11 (gait freezing) of the MDS-UPDRS (MDS-
UPDRSgait) [14].
To assess the construct validity, we search for positive correlations between the
scores at full and short DYPAGS and the FOG-Q scores, PDQ-39mobility, levodopa
equivalent daily doses and disease duration.
2.4.5. Post hoc analysis
The correlations between the full and short DYPAGS scores and the disease
duration and levodopa equivalent daily doses were only moderate (see results). This
ﬁnding was probably related to the variable level of gait improvement after dopa-
minergic drugs intake in our cohort of patients. We veriﬁed whether both DYPAGS
versions and TMTgait and MDS-UPDRSgait were predictive of the response of gait
disturbances to dopaminergic drugs. To perform this analysis, we used the coefﬁcient
of determination R2 [20] between the scores at these instruments and the gait
improvement related to dopaminergic drugs measured using a 10 point-visual
analog scale (scores of 0 and 10 reﬂected absent and optimal responses, respectively).3. Results
3.1. DYPAGS administration
On average, the DYPAGS was safely administered in 4e8min. All
items could be scored in all patients even in those with severe
disability.3.2. Statistical analyses
3.2.1. Scale construction
All items scores showed moderate to high correlation with one
another, in particular the paired “turning” (rs ¼ 0.86) and “imagi-
nary obstacle avoidance” (rs ¼ 0.91). Items testing the less affected
side (that may be considered as the preferred side) were selected as
they globally better reﬂected the patients’ gait disturbances
(Table 2) and were easier to administer.Scale (DYPAGS). Scores colored in light-gray and dark-gray represent scores liberally
ted on short DYPAGS items. * ¼ performed with the less affected side/leg.
tion of the Dynamic Parkinson Gait Scale (DYPAGS), Parkinsonism and
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Fig. 1A). The principal component analysis of the short DYPAGS
revealed one component accounting for 70.9% of the variance. The
remaining components were not considered as they accounted for
very little variance relatively to the ﬁrst component. All items had
adequate loadings on the ﬁrst component excepted “passing
through tight quarters” which was however very close to the rec-
ommended level of salience (Fig. 1B).
3.2.2. Severity of gait disturbances in the patients cohort
Our population of patients showed a wide range of gait distur-
bances. Both full and short DYPAGS did not show any signiﬁcant
ﬂoor or ceiling effect (Fig. 1A). The mean score was close to the
corresponding median score (Table 1).
3.2.3. Reliability of the scales
As assessed with aCronbach, the internal consistency of the scales
and their items was excellent. Exception to walking backwards, the
correlations between items and corrected DYPAGS scores were
strongly positive (Table 3).
All the items used for the assessment of the interrater reliability
passed the acceptable level of aKrippendorff and showed strong
WKendall and ICC (Table 3).
As a comprehensive measure of the precision, SEMs of full and
short DYPAGS were 2.06 and 1.75, respectively. Minimal detectable
changes of the full DYPAGS (5.71) and its shorter version (4.48)
corresponded to 14.3% and 14.9% of their maximumpossible scores,
respectively.
3.2.4. Validity of the scales
As an assessment of the criterion-related validity, the full and
short DYPAGS scores correlated negatively with those at the TMTgait
and positively with those at the MDS-UPDRSgait.
The construct validity was assessed by strong correlations
between scores at both DYPAGS versions and those at the FOG-Q
and PDQ-39mobility. In PD patients (n ¼ 32), the correlations with
the disease duration and levodopa equivalent daily doses were
moderate and close to the severe signiﬁcance threshold imposed by
the Bonferroni correction (Table 1).
3.2.5. Post hoc analysis
Both full and short DYPAGS strongly correlated (R2 ¼ 0.64 and
0.62, respectively) with the patients’ subjective perception of gaitTable 3






Turning to the less affected side 0.94
Turning to the more affected side 0.94
Imaginary obstacle avoidance with the less affected leg 0.93
Imaginary obstacle avoidance with the more affected leg 0.93
Passing through tight quaters 0.93
Walking þ dual-task 0.95
Total DYPAGS score 0.95
Total short DYPAGS score 0.94
* ¼ values obtained on 6 items, excluding imaginary obstacle avoidance. ** ¼ values obta
avoidance. n/a ¼ not applicable.
a Cronbach’s alpha: 0.90 ¼ excellent.
b Spearman’s rank correlation testing: 0.70 ¼ strong.
c Kendall’s coefﬁcient of concordance: 0.75 ¼ acceptable.
d Krippendorff’s alpha: 0.67 ¼ acceptable.
e Intraclass correlation coefﬁcient: 0.75 ¼ acceptable.
Please cite this article in press as: Crémers J, et al., Construction and valida
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UPDRSgait and TMTgait (R2 ¼ 0.47 and 0.40, respectively) did not
reach the same level of correlation.
4. Discussion
The DYPAGS consists in eight relevant items adapted from
instruments previously used to assess gait disturbances in PD.
Walking forwards 7 m represents the “baseline gait”. It reﬂects
commondaily living gait efforts, such aswalking from the front door
to the letterbox. Walking backwards on short distances is an
unavoidable daily task like backing out of the closet after removing
an item of clothing [4]. Turning is very frequent (a direction change
occurs every ten steps) [22] and may strongly provoke gait distur-
bances when performed in small places [1,3]. Obstacle avoidance is
common (e.g., stepping over a gutter when walking on a sidewalk)
and is likely to elicit typical PD-related gait disturbances [23].
Passing between two chairs was used to investigate tight quarters-
related disturbances. Itmay reﬂect a frequent aspect of the daily gait
pattern such as passing between two shopping trolleys in a super-
market. Mobility in daily life frequently requires walking while
performing simultaneous cognitive tasks such as talking with
a person. This was investigated by asking the patients to walk while
quoting animal names which demands a higher cognitive load than
automatic tasks such as counting backwards as used in other
instruments [11] and is therefore more sensitive. The scoring algo-
rithm followed a stepwise judgment that allowed detecting and
quantifying classical features distributed along a continuum that
ranges from subtle hesitation to gait akinesia [1,3].
On average, the DYPAGS was quickly and safely administered. A
wide range of PD-related gait disturbances was observed in our
population of patients without any signiﬁcant ﬂoor or ceiling effect
(Fig. 1A).
A particular issue was the possibility of item redundancy.
Indeed, the scores at paired items involving both sides were
strongly correlated. They also showed signiﬁcant differences which
were expected as gait disturbances are related to altered symmetry
in PD [1]. A 6 item-shorter version of the DYPAGS was subsequently
designed using only the “turning” and “imaginary obstacle avoid-
ance” items involving the less affected side (which could be
considered as the preferred side) because more easily administered
and better correlated with the degree of PD-related gait distur-
bances assessed with valid methods (Table 2). The short DYPAGS isic Parkinson Gait Scale (DYPAGS).
y Interrater reliability
Corrected correlationb WKendallc aKrippendorffd ICCe
0.70 0.84 0.72 0.87
0.58 0.89 0.77 0.89
0.78 0.89 0.78 0.82
0.77 0.88 0.78 0.84
0.88 n/a n/a n/a
0.84 n/a n/a n/a
0.73 0.79 0.70 0.86
0.72 0.79 0.69 0.80
n/a 0.90* 0.83* 0.94*
n/a 0.91** 0.81** 0.94**
ined on 5 items, excluding turning to the more affected side and imaginary obstacle
tion of the Dynamic Parkinson Gait Scale (DYPAGS), Parkinsonism and
Appendix: Dynamic Parkinson Gait Scale (DYPAGS).
Dynamic Parkinson Gait Scale (DYPAGS)
Score
1. Walking 7 m forwards
Normal 0
Subtle start hesitation (<1 s) or
slow gait or increased double-support time
1
Start hesitation >1 s or destination
hesitation or impaired feet clearance
2
Block or accelerated short steps 3
Unable to perform the entire distance or near fall 4
Unable to initiate a step forward or fall 5
2. Walking 3 m backwards
Normal 0
Subtle start hesitation (<1 s) or slow gait or
increased double-support time
1
Start hesitation >1 s or destination hesitation
or impaired feet clearance
2
Block or accelerated short steps 3
Unable to perform the entire distance or near fall 4
Unable to initiate a step backward or fall 5
3. Turning 360 on the same place to the righta
Normal 0
Subtle start hesitation (<1 s) or 8 steps 1
Start hesitation >1 s or 10 steps 2
15 steps or block 3
Unable to complete 360 turning or near fall 4
Unable to initiate turning or fall 5
4. Turning 360 on the same place to the lefta
Normal 0
Subtle start hesitation (<1 s) or 8 steps 1
Start hesitation >1 s or 10 steps 2
15 steps or block 3
Unable to complete 360 turning or near fall 4
Unable to initiate turning or fall 5
5. Stepping over an imaginary obstacle with the right legb
Step amplitude > 0.5  patient’s height 0
Step amplitude ¼ 0.4  patient’s
height  0.5  patient’s height
1
Step amplitude ¼ 0.3  patient’s
height  0.4  patient’s height
2
Step amplitude ¼ 0.2  patient’s
height  0.3  patient’s height
3
Step amplitude < 0.2  patient’s height 4
Unable to initiate a step forward 5
6. Stepping over an imaginary obstacle with the left legb
Step amplitude > 0.5  patient’s height 0
Step amplitude ¼ 0.4  patient’s
height  0.5  patient’s height
1
Step amplitude ¼ 0.3  patient’s
height  0.4  patient’s height
2
Step amplitude ¼ 0.2  patient’s
height  0.3  patient’s height
3
Step amplitude < 0.2  patient’s height 4
Unable to initiate a step forward 5
7. Passing through tight quarters
No hesitation 0
Subtle hesitation (<1 s) or shufﬂing of ﬁrst step 1
Start hesitation ¼ 1e2 s or impaired feet
clearance within tight quarters
2
Start hesitation ¼ 2e5 s or accelerated short
steps within tight quarters
3
Start hesitation ¼ 5e10 s or block within tight
quarters or near fall
4
Start hesitation > 10 s or unable to initiate a step
forward or fall
5
(continued on next page)
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the variance of its total score (Fig. 1B). However, compared with the
full DYPAGS, it does not investigate both sides and is therefore
probably less sensitive.
Although passing through narrow spaces commonly elicits gait
disturbances in PD [1,3], it was less involved in the short DYPAGS
variance relatively to the other items (Fig. 1B). This ﬁnding was
probably due to the condition used in the scale (a 50 cm-space
made between two chairs) which imperfectly simulates tight
quarters like a doorframe. Passing through a doorframe should be
used in the future rather than the current condition.
The scales showed excellent internal consistency using aCronbach.
Contrarily to the other items, the correlation between the “walking
backwards” and the corrected DYPAGS scores did not reach the
acceptable level (Table 3). This result was probably due to the
higher sensitivity of this condition [4].
All 6 items scored by visual inspection of video data (Table 3)
passed the acceptable level of interrater reliability determined using
validated methods [18e20]. The precision of the scales was assessed
by SEMs <50% to their corresponding standard deviation [20]. The
scales showed acceptable minimal detectable change expressed as
the percentage of the maximum possible score.
The criterion-related validity of the full and short DYPAGS
(Table 1) was assessed by strong correlations between their indi-
vidual scores and those at other dynamic instruments useful to
assess gait disturbances in PD [8,14,21].
The construct validity was assessed by strong positive correla-
tions between scores at both full and short DYPAGS and those at the
FOG-Q, PDQ-39mobility, and moderate with the disease duration and
levodopa equivalent daily doses (Table 1). The rationale for such an
approach was the intrinsic evidence that patients with “on” PD-
related gait disturbances should have more habitual gait freezing,
and the evidence of altered quality of life [24,25], longer disease
duration and levodopa treatment [26,27] in PD patients with
typical gait disturbances.
Compared with the MDS-UPDRSgait and TMTgait, both full and
short DYPAGS were the best to predict the patients’ subjective level
of gait improvement related to the current dopaminergic treat-
ment. Although these results were obtained using a non-validated
procedure and must be cautiously interpreted, this feature of the
scales may be useful to assess the efﬁcacy of speciﬁc therapeutic
approaches aiming at alleviating PD-related gait disturbances such
as complete readjustment of the dopaminergic treatment or deep
brain stimulation. We plan to further examine the sensitivity to
change of the scales in patients receiving such treatments and to
verify whether the scores are consistent with the judgment of
clinicians with special expertise in PD. The opinion of experts may
be helpful to determine whether the scales overestimate the gait
disturbances in some patients (e.g., elderly patients with mild PD)
due to other conditions than PD.
Overall, the full and short DYPAGS are reliable instruments for
the dynamic quantiﬁcation of “on” PD-related episodic gait
disturbances. The full version may be useful to detect subtle
disturbances due to altered gait symmetry in patients with mild
parkinsonismwhereas the shorter one, more easily administered, is
probably sufﬁcient to evaluate gait disturbances in moderate to
severe disease. We recommend their use for research purposes and
clinical practice.
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Appendix (continued)
Dynamic Parkinson Gait Scale (DYPAGS)
Score
8. Walking while performing a cognitive dual-task (quoting
animal names)
Normal 0
Subtle start hesitation (<1 s) or slow gait
or increased double-support time
1
Start hesitation >1 s or destination hesitation
or impaired feet clearance or <6 items quoted
2
Block or accelerated short steps 3
Unable to perform the entire distance or
near fall
4
Unable to initiate a step forward or fall 5
Total DYPAGS score __/40
Total short DYPAGS score __/30
Block ¼ a period when the foot is stuck onto the ground for more than 1 s with or
without trembling in place.
a In the short DYPAGS, only turning to the preferred side is scored.
b In the short DYPAGS, only stepping over an imaginary obstacle with the
preferred leg is scored.
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